Advancing Epigenetic and Antioxidant Strategies in Natural Therapeutics Against SARS-CoV-2: A Mini Review of Current Innovations and Future Directions
- 1 November 2025
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in The Natural Products Journal
- Vol. 15 (8) , 1-11
Abstract
This review explores the potential of natural products, particularly curcumin and gingerol, as immune regulators and anti-inflammatory agents in combating SARS-CoV-2 infections via epigenetic and antioxidant mechanisms. Oxidative stress induced by coronavirus infections can trigger severe immune responses, such as cytokine storms, often leading to therapy failure. This oxidative stress is exacerbated by depleted antioxidant defenses. The review examines how natural ingredients activate endogenous antioxidants through pathways like nuclear factor erythroid 2-related factor 2 (Nrf-2) activation, leading to gene expression changes without altering DNA structure. These changes enhance cellular defenses against oxidative stress and reduce inflammation, potentially mitigating the virus's effects. The methodology involved a literature review of scientific articles from databases such as Google Scholar, Elsevier, Science Direct, Scopus, and Wiley Online Library, focusing on publications from 2010 to 2023. Data were analyzed using deductive qualitative descriptive techniques, emphasizing the role of natural compounds in activating antioxidant responses to prevent or minimize cellular damage caused by COVID-19. The review underscores the significant role of diet and nutritional intake in supporting the body's antioxidant capacity by activating specific receptors that influence gene expression related to immune responses and cellular repair mechanisms. Flavonoids and anthocyanins are highlighted as key compounds in natural products with therapeutic potential against COVID-19. Overall, this research advocates for further exploration of natural products as viable options for preventing and treating COVID-19, suggesting that these compounds offer dual benefits of antiviral activity and immune modulation through epigenetic regulation and antioxidant support.Keywords
This publication has 73 references indexed in Scilit:
- Epigenetic regulation in cancerMedcomm, 2024
- In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2Molecular Diversity, 2021
- Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLproAntiviral Research, 2021
- Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalizationMolecular and Cellular Biochemistry, 2020
- ACE2: The Major Cell Entry Receptor for SARS-CoV-2Lung, 2020
- Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A ReviewThe Protein Journal, 2020
- Structure analysis of the receptor binding of 2019-nCoVBiochemical and Biophysical Research Communications, 2020
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic targetIntensive Care Medicine, 2020
- Inhibitory Effect of Alpha-Mangostin to Dengue Virus Replication and Cytokines Expression in Human Peripheral Blood Mononuclear CellsNatural Products and Bioprospecting, 2019
- Flavonoids: promising natural compounds against viral infectionsArchives of Virology, 2017